SALMON EVOLUTION ASA (SALME.OL) Stock Fundamental Analysis
OSL:SALME - Euronext Oslo - NO0010892094 - Common Stock - Currency: NOK
We assign a fundamental rating of 3 out of 10 to SALME. SALME was compared to 57 industry peers in the Food Products industry. SALME has a bad profitability rating. Also its financial health evaluation is rather negative. SALME shows excellent growth, but is valued quite expensive already.
1. Profitability
1.1 Basic Checks
In the past year SALME has reported negative net income.
In the past year SALME had a positive cash flow from operations.
SALME had negative earnings in each of the past 5 years.
In the past 5 years SALME reported 4 times negative operating cash flow.
1.2 Ratios
The Return On Assets of SALME (-2.87%) is worse than 75.44% of its industry peers.
SALME's Return On Equity of -4.54% is on the low side compared to the rest of the industry. SALME is outperformed by 75.44% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.87% | ||
| ROE | -4.54% | ||
| ROIC | N/A |
ROA(3y)-2.76%
ROA(5y)-2.34%
ROE(3y)-3.94%
ROE(5y)-3.2%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Gross Margin, with a value of 65.28%, SALME belongs to the top of the industry, outperforming 92.98% of the companies in the same industry.
In the last couple of years the Gross Margin of SALME has declined.
SALME does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 65.28% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-11.83%
GM growth 5YN/A
2. Health
2.1 Basic Checks
SALME does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, SALME has more shares outstanding
The number of shares outstanding for SALME has been increased compared to 5 years ago.
The debt/assets ratio for SALME has been reduced compared to a year ago.
2.2 Solvency
SALME has an Altman-Z score of 1.41. This is a bad value and indicates that SALME is not financially healthy and even has some risk of bankruptcy.
SALME has a worse Altman-Z score (1.41) than 71.93% of its industry peers.
A Debt/Equity ratio of 0.39 indicates that SALME is not too dependend on debt financing.
The Debt to Equity ratio of SALME (0.39) is better than 71.93% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.39 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.41 |
ROIC/WACCN/A
WACC7.92%
2.3 Liquidity
SALME has a Current Ratio of 1.80. This is a normal value and indicates that SALME is financially healthy and should not expect problems in meeting its short term obligations.
SALME's Current ratio of 1.80 is fine compared to the rest of the industry. SALME outperforms 70.18% of its industry peers.
A Quick Ratio of 1.29 indicates that SALME should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.29, SALME is in the better half of the industry, outperforming 77.19% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.8 | ||
| Quick Ratio | 1.29 |
3. Growth
3.1 Past
SALME shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 21.43%, which is quite impressive.
SALME shows a strong growth in Revenue. In the last year, the Revenue has grown by 67.45%.
Measured over the past years, SALME shows a very strong growth in Revenue. The Revenue has been growing by 238.62% on average per year.
EPS 1Y (TTM)21.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-3806.9%
Revenue 1Y (TTM)67.45%
Revenue growth 3Y238.62%
Revenue growth 5YN/A
Sales Q2Q%-50.46%
3.2 Future
The Earnings Per Share is expected to grow by 80.97% on average over the next years. This is a very strong growth
Based on estimates for the next years, SALME will show a very strong growth in Revenue. The Revenue will grow by 48.21% on average per year.
EPS Next Y109.36%
EPS Next 2Y74.45%
EPS Next 3Y92.99%
EPS Next 5Y80.97%
Revenue Next Year15.78%
Revenue Next 2Y30.97%
Revenue Next 3Y51.3%
Revenue Next 5Y48.21%
3.3 Evolution
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
SALME reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
A Price/Forward Earnings ratio of 52.97 indicates a quite expensive valuation of SALME.
Based on the Price/Forward Earnings ratio, SALME is valued a bit more expensive than the industry average as 71.93% of the companies are valued more cheaply.
SALME is valuated expensively when we compare the Price/Forward Earnings ratio to 22.19, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 52.97 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, SALME is valued expensively inside the industry as 85.96% of the companies are valued cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 78.66 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as SALME's earnings are expected to grow with 92.99% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y74.45%
EPS Next 3Y92.99%
5. Dividend
5.1 Amount
No dividends for SALME!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
OSL:SALME (6/19/2025, 4:19:47 PM)
6.08
+0.05 (+0.83%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)
Earnings (Next)
Inst Owners21.67%
Inst Owner ChangeN/A
Ins Owners2.19%
Ins Owner ChangeN/A
Market Cap2.81B
Analysts85
Price Target9.52 (56.58%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-742.73%
Min EPS beat(2)-1265.05%
Max EPS beat(2)-220.42%
EPS beat(4)1
Avg EPS beat(4)-391.97%
Min EPS beat(4)-1265.05%
Max EPS beat(4)6.04%
EPS beat(8)2
Avg EPS beat(8)-212.49%
EPS beat(12)6
Avg EPS beat(12)-132.81%
EPS beat(16)9
Avg EPS beat(16)-97.7%
Revenue beat(2)1
Avg Revenue beat(2)-20.97%
Min Revenue beat(2)-43.93%
Max Revenue beat(2)1.98%
Revenue beat(4)1
Avg Revenue beat(4)-21.8%
Min Revenue beat(4)-43.93%
Max Revenue beat(4)1.98%
Revenue beat(8)3
Avg Revenue beat(8)-21.1%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.21%
PT rev (3m)-4.49%
EPS NQ rev (1m)-165.63%
EPS NQ rev (3m)-165.63%
EPS NY rev (1m)0%
EPS NY rev (3m)-57.89%
Revenue NQ rev (1m)-32.72%
Revenue NQ rev (3m)-32.72%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-4.61%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 52.97 | ||
| P/S | 6.7 | ||
| P/FCF | N/A | ||
| P/OCF | 72.91 | ||
| P/B | 1.3 | ||
| P/tB | 1.35 | ||
| EV/EBITDA | 78.66 |
EPS(TTM)-0.22
EYN/A
EPS(NY)0.11
Fwd EY1.89%
FCF(TTM)-1.14
FCFYN/A
OCF(TTM)0.08
OCFY1.37%
SpS0.91
BVpS4.69
TBVpS4.52
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -2.87% | ||
| ROE | -4.54% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 65.28% | ||
| FCFM | N/A |
ROA(3y)-2.76%
ROA(5y)-2.34%
ROE(3y)-3.94%
ROE(5y)-3.2%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-11.83%
GM growth 5YN/A
F-Score4
Asset Turnover0.12
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.39 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 19.69 | ||
| Cap/Depr | 717.36% | ||
| Cap/Sales | 135.14% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | 89.28% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.8 | ||
| Quick Ratio | 1.29 | ||
| Altman-Z | 1.41 |
F-Score4
WACC7.92%
ROIC/WACCN/A
Cap/Depr(3y)4495.02%
Cap/Depr(5y)15899.7%
Cap/Sales(3y)642.51%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)21.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-3806.9%
EPS Next Y109.36%
EPS Next 2Y74.45%
EPS Next 3Y92.99%
EPS Next 5Y80.97%
Revenue 1Y (TTM)67.45%
Revenue growth 3Y238.62%
Revenue growth 5YN/A
Sales Q2Q%-50.46%
Revenue Next Year15.78%
Revenue Next 2Y30.97%
Revenue Next 3Y51.3%
Revenue Next 5Y48.21%
EBIT growth 1Y64.24%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year73454.1%
EBIT Next 3Y1493.28%
EBIT Next 5Y543.98%
FCF growth 1Y26.92%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y126.89%
OCF growth 3YN/A
OCF growth 5YN/A